Teresa Marie Volner alias The Glucose Chiro

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Manage Type 2 Diabetes with Genetic Testing.

Manage Type 2 Diabetes with Genetic Testing

Supports

There is emerging, but limited, evidence that incorporating genetic information into the care of people with type 2 diabetes can modestly influence management processes or patient behaviors, though not clearly improve glycemic outcomes. A randomized clinical trial (GEM trial) in patients with type 2 diabetes used genetic testing for risk alleles related to complications and provided personalized genetic risk counselling; this improved self-efficacy and some attitudes but did not meaningfully improve hard clinical targets (blood pressure, lipids, HbA1c) beyond standard integrated care.^[1] Reviews of pharmacogenetics in type 2 diabetes describe many gene–drug response associations and suggest that, if genotypes were routinely available, they could help refine drug choice and dosing as part of precision medicine strategies, though this is framed as future potential rather than current routine practice.^[8][9][10] Precision medicine and personalized medicine reviews in diabetes note that genetic testing is clearly useful for monogenic diabetes (such as maturity-onset diabetes of the young) to guide diagnosis and choice of therapy, and argue that as genomic information becomes more available, it may increasingly support individualized management.^[5][10][16]

Contradicts

High-quality evidence and current guidelines do not support the idea that genetic testing, as currently used, is a primary or stand‑alone tool to manage typical polygenic type 2 diabetes, nor that it reliably improves glycemic control or replaces established lifestyle and pharmacologic interventions. In the randomized GEM trial, adding genetic risk counselling based on testing did not significantly improve achievement of cardiometabolic targets compared with usual integrated care, indicating no clear clinical benefit on key outcome measures.^[1] Pharmacogenomic reviews emphasize that type 2 diabetes is highly polygenic with many small‑effect variants, so the clinical impact of individual pharmacogenetic markers is modest, and current genetic tests do not robustly define pathophysiology or guide treatment decisions in routine type 2 diabetes care.^[8][9][10] Major contemporary guidelines for type 2 diabetes in adults and youth focus on glycemic targets, lifestyle modification, and evidence‑based drug algorithms (metformin, GLP‑1 receptor agonists, SGLT2 inhibitors, insulin, etc.), and do not recommend routine genetic testing to manage standard type 2 diabetes; genetic testing is mainly discussed for differentiating monogenic diabetes or rare insulin‑resistance syndromes and for classification, not as a core management tool.^{[10][11][16][20]} Overall, the evidence base for using genetic testing to drive day‑to‑day management of typical type 2 diabetes is weak, mainly conceptual or exploratory, and lacks large RCTs showing improved clinical outcomes compared with standard care.^[8][9][10]

Mainstream view

The mainstream medical position is that management of type 2 diabetes should be based primarily on lifestyle modification, structured self‑management education, regular monitoring of glycemia, and stepwise use of validated pharmacologic therapies guided by clinical features and complications rather than by routine genetic testing.^{[4][7][13][17][19]} Genetic factors are recognized as important contributors to risk and to rare diabetes subtypes, and genetic testing is recommended or strongly considered when monogenic diabetes (such as MODY) or atypical forms (for example, type A insulin resistance) are suspected, because results can significantly change diagnosis and treatment strategy.^{[10][11][16][20]} For the common polygenic form of type 2 diabetes, expert reviews and guidelines view pharmacogenomics and genomic risk scores as promising tools for future precision medicine but not yet validated or cost‑effective for routine management; their use is largely confined to research or specialized settings.^{[5][8][9][10]} Mainstream care therefore does not endorse the idea of “managing type 2 diabetes with genetic testing” as a primary or sufficient strategy, but rather sees genetic information as an adjunct that may occasionally refine classification or therapy choice, especially in non‑typical cases.^{[5][10][16][20]}

In their own wordsView sourceArchived copy

“Manage Diabetes With Genetic Testing & Transform With Certainty.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type 2 diabetes can be traced to DNA / genetics as the hidden root cause.

Type 2 diabetes can be traced to DNA / genetics as the hidden root cause

Supports

High-quality evidence shows that type 2 diabetes has a substantial genetic component: twin and family studies consistently estimate heritability in the roughly 25–80% range, with several large cohorts and meta-analyses clustering around 50–72% heritability.^{[8][9][10][11][12][14][15][16][19]} Concordance rates for type 2 diabetes are markedly higher in monozygotic than dizygotic twins, indicating that sharing more DNA increases risk, which supports a major role for genetics in susceptibility.^{[9][11][12][14][19]} First‑degree relatives of people with type 2 diabetes have about a three‑fold higher risk compared with those without a family history, and risk may approach 40–70% if one or both parents are affected, again indicating strong familial and genetic influence.^[12][14] Genome‑wide association studies have identified over a hundred common risk variants and many loci that contribute to a polygenic risk background for type 2 diabetes, supporting the idea that DNA variants substantially influence overall risk.^{[13][14][16][18]} Systematic reviews and meta‑analyses in various populations, including Sub‑Saharan Africa, show that having a positive family history is associated with roughly a three‑fold higher odds of type 2 diabetes and identify specific risk polymorphisms (for example in TCF7L2 and other genes) that contribute to disease susceptibility.^[6] Authoritative reviews and genetic overviews describe type 2 diabetes as developing on a predisposing genetic background onto which environmental factors are superimposed, reinforcing the view that genetics forms a key, though not exclusive, part of the disease etiology.^{[1][8][12][14][19]}

Contradicts

Although genetics clearly contributes to type 2 diabetes risk, high‑quality evidence does not support the idea that DNA or genetics alone are the hidden root cause in a simple or deterministic sense, because heritability estimates are moderate to high but far from 100%, and they vary substantially across studies and populations.^{[8][9][10][11][14][16][19]} Twin studies and population‑based analyses repeatedly emphasize a multifactorial etiology, concluding that non‑genetic factors play a predominant role in determining whether a genetically predisposed individual progresses to overt type 2 diabetes.^[11][19] Some cohorts, such as the Washington State Twin Registry, show heritability around 52% in older adults and little or no detectable genetic contribution in twins under 45, indicating that environmental and lifestyle factors become increasingly important and that DNA is not sufficient by itself to explain disease onset.^[10][5][19] Reviews of gene–environment interaction and epigenetic work highlight that even among identical twins, one can develop type 2 diabetes while the other does not, with differences in gene activity and epigenetic marks linked to diet, adiposity, and other exposures, directly contradicting a purely DNA‑centric causal framing.^[17][19][20] Environmental and lifestyle factors such as obesity, diet, physical inactivity, and broader metabolic and social determinants are recognized as major drivers of type 2 diabetes incidence worldwide, often necessary to unmask genetic susceptibility, which weakens any claim that genetics alone is the root cause.^[1][19][20] Major reviews explicitly state that a susceptible genetic background appears to be necessary for overt diabetes only in rare monogenic or Mendelian forms, not in typical type 2 diabetes, and that most common cases arise from complex interactions between genes and environment.^{[1][12][14][19]}

Mainstream view

The mainstream medical and scientific position is that type 2 diabetes is a complex, multifactorial disease caused by the interaction of a substantial but incomplete genetic predisposition with environmental and lifestyle factors such as obesity, diet, and physical activity.^{[1][8][12][14][19][20]} Current evidence indicates that DNA and genetics confer important susceptibility and explain a significant proportion of variance in risk, but they do not function as a single hidden root cause, because many genetically predisposed individuals never develop the disease and many environmental changes can markedly modify risk and disease trajectory.^{[10][11][19][20]} Expert reviews, twin studies, and genomic research converge on a model in which type 2 diabetes arises from a polygenic background, epigenetic modifications, and metabolic mechanisms that are strongly shaped by modifiable exposures, so standard practice is to treat genetics as one key layer within a broader causal framework rather than the primary or sole origin of disease.^{[1][8][12][14][19][20]} Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“What If the Secret to Reversing Type 2 Diabetes Has Been in Your DNA All Along?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism.

The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism

Supports

There is substantial evidence that structured lifestyle and behavioral programs can improve blood sugar control in people with type 2 diabetes, particularly when they include diet, physical activity, and education, similar in concept to what the WINNERS in Diabetes Program claims to do, although this specific program itself has no indexed trials or peer‑reviewed evaluations identified. ^[8] Randomized and quasi‑experimental studies of comprehensive or commercial diabetes-tailored weight‑loss and behavior programs (e. g. , community and online programs, general comprehensive treatment programs, and commercial weight‑loss programs tailored for type 2 diabetes) consistently show modest but clinically relevant reductions in HbA1c and fasting blood glucose, supporting the general idea that a multi-component program can improve glycemic control and aspects of metabolism. ^[14][15][16] Online‑supervised exercise programs in older adults with type 2 diabetes have been shown in double‑blind randomized trials to lower fasting blood sugar, improve BMI, and enhance quality of life, supporting the claim that structured, supervised lifestyle interventions can improve blood sugar stability, energy, and overall metabolic health. ^[13] Family-based and community health behavior change interventions for diabetes show improved self-management and glycemic control, which indirectly supports the concept that coaching and social support as used in the program can help stabilize blood sugar and improve energy levels. ^[7] Dietary interventions such as the DASH diet and cinnamon supplementation have demonstrated improvements in fasting blood glucose and HbA1c, supporting that specific nutrition strategies embedded in a program can contribute to blood sugar stability and cardiometabolic health. Pharmacologic dopamine agonists (e. g. , bromocriptine) are FDA-approved for type 2 diabetes and systematic reviews and meta-analyses show they modestly lower HbA1c and fasting plasma glucose, supporting the broader mechanistic notion that targeted interventions on metabolism and neuroendocrine pathways can influence blood sugar regulation and metabolic variables.

Contradicts

No peer-reviewed trials, observational studies, or guideline documents specifically evaluating the WINNERS in Diabetes Program were identified, so there is no direct evidence that this branded program itself restores balance or stabilizes blood sugar, energy, digestion, and metabolism beyond generic expectations from lifestyle programs. ^[7] The program’s marketing claims of putting diabetes in remission naturally and restoring multiple domains (blood sugar stability, energy, digestion, metabolism) imply large and consistent effects; available evidence for analogous programs shows benefits that are typically modest in magnitude and variable across individuals, with glycemic improvements on the order of 0. ^[13][15][16] 3–1. 2% reductions in HbA1c rather than guaranteed remission. Existing high‑quality evidence for lifestyle and commercial programs largely focuses on glycemic outcomes, weight, and cardiometabolic risk factors, and does not consistently demonstrate specific improvements in digestion or global “metabolic balance” as broad claims, so the assertion that a proprietary program restores overall balance and digestion exceeds what is directly supported by clinical trials. ^[14] Systematic reviews of dopamine agonists and metabolic modulation show only moderate to low quality evidence and modest glycemic effects, highlighting that even well-studied targeted pharmacologic interventions do not typically produce the comprehensive, multi-domain restoration implied by the influencer’s claim. Major nutrition guidelines for chronic disease (ESPEN and ASPEN‑FELANPE) emphasize individualized clinical nutrition and appropriate use of enteral and parenteral support, but they do not endorse specific commercial programs like WINNERS in Diabetes, nor do they claim such programs can, by themselves, restore global metabolic balance or cure diabetes. ^[6][5][8]

Mainstream view

Mainstream medical and scientific consensus is that type 2 diabetes is a chronic metabolic disease that can be substantially improved and sometimes brought into remission through evidence‑based interventions including structured lifestyle change (diet, physical activity, weight loss), appropriate pharmacotherapy, and management of comorbidities, but claims of universal remission or comprehensive restoration of balance from a single proprietary program are not supported without rigorous clinical trial data. ^{[7][6][5][8][15][16]} High‑quality evidence supports multi-component lifestyle and behavior change programs, including diabetes‑tailored commercial weight‑loss interventions, supervised exercise programs, and dietary strategies such as DASH Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). ^[13][14]

In their own wordsView sourceArchived copy

“The WINNERS in Diabetes Program is a personalized system designed to restore balance to your body from blood sugar stability to energy, digestion, and metabolism.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure DNA and oxidative stress testing can guide personalized diabetes management.

DNA and oxidative stress testing can guide personalized diabetes management

Supports

Oxidative stress is mechanistically linked to diabetes and its complications, and multiple reviews describe oxidative biomarkers such as 8-OHdG, MDA, and isoprostanes as potential markers of disease burden or complication risk. ^[19][20] A recent review also argues that oxidative stress biomarkers may help refine diagnosis, counseling, and personalized care in selected contexts, but it frames this as future-facing and context-dependent rather than established routine diabetes management. ^[17] The broader precision-medicine literature in diabetes supports using certain biomarkers and genotype information to tailor therapy in limited scenarios, such as C-peptide, HNF1A MODY, CYP2C9 variants affecting sulfonylurea response, and OCT1 variants affecting metformin intolerance. ^[18]

Contradicts

The evidence does not support routine DNA testing plus oxidative stress testing as a validated way to guide personalized diabetes management for most patients. ^[7][17][19] A recent review states that no oxidative stress biomarker has shown consistently replicated incremental prognostic value beyond established cardiometabolic risk models sufficient for routine clinical implementation, and that oxidative biomarkers remain primarily mechanistic and research tools. ^[5][18][20] The same review notes that lowering oxidative biomarkers has not been established as a validated mediator of clinical benefit. The diabetes precision-medicine reviews support genetics-guided care only for narrow, specific subgroups, not broad influencer-style claims that DNA testing in general can direct diabetes treatment for typical patients.

Mainstream view

Mainstream endocrinology and laboratory medicine view oxidative stress biomarkers as biologically interesting and potentially useful in research or limited specialist settings, but not as standard-of-care tools for routine personalized diabetes management. ^{[17][18][19][20]} Mainstream precision diabetes care uses established clinical measures and selectively uses genetics in a few well-defined scenarios, rather than general DNA or oxidative stress testing for all patients. ^[5] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Manage Type 2 Diabetes with DNA and Oxidative Stress Testing”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The program helps prevent kidney issues, nerve damage, and vision loss in diabetes.

The program helps prevent kidney issues, nerve damage, and vision loss in diabetes

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Assess your genetic odds to help prevent kidney issues, nerve damage and vision loss.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Winners in Diabetes Program.

Winners in Diabetes Program

Supports

There is substantial evidence that structured lifestyle and behavioral programs can improve blood sugar control in people with type 2 diabetes, particularly when they include diet, physical activity, and education, similar in concept to what the WINNERS in Diabetes Program claims to do, although this specific program itself has no indexed trials or peer‑reviewed evaluations identified. ^[8] Randomized and quasi‑experimental studies of comprehensive or commercial diabetes-tailored weight‑loss and behavior programs (e. g. , community and online programs, general comprehensive treatment programs, and commercial weight‑loss programs tailored for type 2 diabetes) consistently show modest but clinically relevant reductions in HbA1c and fasting blood glucose, supporting the general idea that a multi-component program can improve glycemic control and aspects of metabolism. ^[14][15][16] Online‑supervised exercise programs in older adults with type 2 diabetes have been shown in double‑blind randomized trials to lower fasting blood sugar, improve BMI, and enhance quality of life, supporting the claim that structured, supervised lifestyle interventions can improve blood sugar stability, energy, and overall metabolic health. ^[13] Family-based and community health behavior change interventions for diabetes show improved self-management and glycemic control, which indirectly supports the concept that coaching and social support as used in the program can help stabilize blood sugar and improve energy levels. ^[7] Dietary interventions such as the DASH diet and cinnamon supplementation have demonstrated improvements in fasting blood glucose and HbA1c, supporting that specific nutrition strategies embedded in a program can contribute to blood sugar stability and cardiometabolic health. Pharmacologic dopamine agonists (e. g. , bromocriptine) are FDA-approved for type 2 diabetes and systematic reviews and meta-analyses show they modestly lower HbA1c and fasting plasma glucose, supporting the broader mechanistic notion that targeted interventions on metabolism and neuroendocrine pathways can influence blood sugar regulation and metabolic variables.

Contradicts

No peer-reviewed trials, observational studies, or guideline documents specifically evaluating the WINNERS in Diabetes Program were identified, so there is no direct evidence that this branded program itself restores balance or stabilizes blood sugar, energy, digestion, and metabolism beyond generic expectations from lifestyle programs. ^[7] The program’s marketing claims of putting diabetes in remission naturally and restoring multiple domains (blood sugar stability, energy, digestion, metabolism) imply large and consistent effects; available evidence for analogous programs shows benefits that are typically modest in magnitude and variable across individuals, with glycemic improvements on the order of 0. ^[13][15][16] 3–1. 2% reductions in HbA1c rather than guaranteed remission. Existing high‑quality evidence for lifestyle and commercial programs largely focuses on glycemic outcomes, weight, and cardiometabolic risk factors, and does not consistently demonstrate specific improvements in digestion or global “metabolic balance” as broad claims, so the assertion that a proprietary program restores overall balance and digestion exceeds what is directly supported by clinical trials. ^[14] Systematic reviews of dopamine agonists and metabolic modulation show only moderate to low quality evidence and modest glycemic effects, highlighting that even well-studied targeted pharmacologic interventions do not typically produce the comprehensive, multi-domain restoration implied by the influencer’s claim. Major nutrition guidelines for chronic disease (ESPEN and ASPEN‑FELANPE) emphasize individualized clinical nutrition and appropriate use of enteral and parenteral support, but they do not endorse specific commercial programs like WINNERS in Diabetes, nor do they claim such programs can, by themselves, restore global metabolic balance or cure diabetes. ^[6][5][8]

Mainstream view

Mainstream medical and scientific consensus is that type 2 diabetes is a chronic metabolic disease that can be substantially improved and sometimes brought into remission through evidence‑based interventions including structured lifestyle change (diet, physical activity, weight loss), appropriate pharmacotherapy, and management of comorbidities, but claims of universal remission or comprehensive restoration of balance from a single proprietary program are not supported without rigorous clinical trial data. ^{[7][6][5][8][15][16]} High‑quality evidence supports multi-component lifestyle and behavior change programs, including diabetes‑tailored commercial weight‑loss interventions, supervised exercise programs, and dietary strategies such as DASH Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). ^[13][14]

In their own wordsView sourceArchived copy

“Winners in Diabetes Program”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Full Program.

The WINNERS in Diabetes Full Program

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“The WINNERS in Diabetes Full Program”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure to struggle alone with diabetes.

to struggle alone with diabetes

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“to struggle alone with diabetes”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Why the WINNERS in Diabetes Program Changes Everything.

Why the WINNERS in Diabetes Program Changes Everything

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Why the WINNERS in Diabetes Program Changes Everything”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Q: Can genetic testing predict diabetes?.

Q: Can genetic testing predict diabetes?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Q: Can genetic testing predict diabetes?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Do you have genetic tendencies toward insulin resistance?.

Do you have genetic tendencies toward insulin resistance?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Do you have genetic tendencies toward insulin resistance?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Put Diabetes In Remission Forever!.

Put Diabetes In Remission Forever!

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Put Diabetes In Remission Forever!”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise DNA testing plus lifestyle and supplement recommendations will work for you as within their scope of practice.

DNA testing plus lifestyle and supplement recommendations will work for you

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“It gives food, lifestyle, and supplement recommendations that will work for you.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Teresa Marie Volner is not approved to offer Custom plans combine detox support, targeted nutrition, and clean supplements within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).

Custom plans combine detox support, targeted nutrition, and clean supplements

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Your custom plan combines detox support, targeted nutrition, and clean supplements chosen for your biology.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)